Expression of multiple larger-sized transcripts for several genes in oligodendrogliomas: potential markers for glioma subtype.

[1]  P. Herrlich,et al.  Heterogeneous Ribonucleoprotein A1 Is Part of an Exon-specific Splice-silencing Complex Controlled by Oncogenic Signaling Pathways* , 2000, The Journal of Biological Chemistry.

[2]  Kyunglim Lee,et al.  Expression of translationally controlled tumor protein mRNA in human colon cancer. , 2000, Cancer letters.

[3]  B. Scheithauer,et al.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  B. Silvestrini,et al.  Quantification of prostaglandin D synthetase in cerebrospinal fluid: A potential marker for brain tumor , 1998, Biochemistry and molecular biology international.

[5]  D. Walker,et al.  Expression of complement C4 and C9 genes by human astrocytes , 1998, Brain Research.

[6]  S. Hockfield,et al.  BEHAB/brevican: a brain-specific lectican implicated in gliomas and glial cell motility , 1998, Current Opinion in Neurobiology.

[7]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[8]  V. P. Collins,et al.  A high ratio of insulin-like growth factor II/insulin-like growth factor binding protein 2 messenger RNA as a marker for anaplasia in meningiomas. , 1997, Cancer research.

[9]  T. Yamashima,et al.  Prostaglandin D Synthase (β-Trace) in Human Arachnoid and Meningioma Cells: Roles as a Cell Marker or in Cerebrospinal Fluid Absorption, Tumorigenesis, and Calcification Process , 1997, The Journal of Neuroscience.

[10]  J. Gu,et al.  Selenium is required for normal upregulation of myelin genes in differentiating oligodendrocytes , 1997, Journal of neuroscience research.

[11]  M. Schiller,et al.  Stage-specific expression of RESP18 in the testes. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[12]  M. Jackson,et al.  Cloning differentially expressed mRNAs , 1996, Nature Biotechnology.

[13]  C. Auffray,et al.  The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. , 1996, Genomics.

[14]  J. Harney,et al.  Cloning and Functional Characterization of Human Selenophosphate Synthetase, an Essential Component of Selenoprotein Synthesis (*) , 1995, The Journal of Biological Chemistry.

[15]  G. Reifenberger,et al.  Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. , 1994, The American journal of pathology.

[16]  J. Rey,et al.  Molecular analysis of chromosomh 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors , 1994, International journal of cancer.

[17]  S. Gammeltoft,et al.  Gene expression of insulin‐like growth factor II in human intracranial meningioma , 1993, Cancer.

[18]  H. Ng,et al.  Expression of epithelial and extracellular matrix protein markers in meningiomas , 1993, Histopathology.

[19]  T. Lichtor.  Gene expression of apolipoprotein E in human brain tumors , 1992, Neuroscience Letters.

[20]  M. Gurney,et al.  Differential expression of insulin-like growth factor II in human meningiomas. , 1991, Neurosurgery.

[21]  P. Philipov,et al.  Selenium in the treatment of patients with brain gliomas. A pilot study. , 1990, Zentralblatt fur Neurochirurgie.

[22]  W. Halliday,et al.  Intermediate Filaments in Meningiomas , 1985, Journal of neuropathology and experimental neurology.

[23]  R. Schmutzler,et al.  GFAP in brain tumor diagnosis: possibilities and limitations. , 1985, Pathology, research and practice.

[24]  O. G. Dodge,et al.  Histological Typing of tumours of the Central Nervous System , 1981, British Journal of Cancer.